This procedural ruling does not change the fundamental risk profile of the trade-secret litigation. Monitor for upcoming dispositive motions or trial dates that could create material exposure. The denial of discovery is a minor setback but not a case-ending event.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jul 24 $3.97entry
- T+1 · 4mo ago −0.25%α −0.27% · $3.96
- T+5 · 4mo ago +2.02%α +0.92% · $4.05
- T+20 · 3mo ago −2.27%α −5.89% · $3.88
- T+60 · 29d ago −7.30%α −11.03% · $3.68
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
OraSure's motion to reopen fact discovery in its trade-secret litigation against NowDiagnostics was denied by the Eastern District of Pennsylvania. The court adopted the Special Master's recommendation that OraSure lacked diligence and already has sufficient evidence to challenge the opposing declaration. This is a procedural loss that keeps the case on track toward trial or settlement without materially altering the litigation landscape for OraSure.
Court Ruling Details
Key Facts
- OraSure's motion to reopen fact discovery for a limited purpose was denied.
- The court adopted the Special Master's Report and Recommendation finding OraSure lacked diligence.
- OraSure did not file objections to the Special Master's recommendation.
- The case involves competing trade-secret claims over diagnostic test designs.
- OraSure's motion to file under seal was also denied.
Financial Impact
No monetary damages or financial exposure stated in the ruling.
Risk Factors
- Adverse ruling at trial or summary judgment on trade-secret counterclaims could create financial liability.
- Continued litigation costs without resolution.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 court opinion.
| Document | Accession Number |
|---|---|
| COURT-RULING Data (Synthetic) | court-e75c21b2df-OSUR |
Track record
20 reports on OSUR
6 of 6 bullish or bearish reports moved the stock their way by T+1. Best: +39.73% at T+60 after the Mar 13, 2026 report. 6 of 6 went positive at some point.
Filters
- Nov 12, 20264d ago 10-Q/A Neutral 2/10 Entry $3.62 to $3.62 Now $3.60 −0.55% · 0.00% +0.36% vs SPY
- Nov 9, 20267d ago Press Release Neutral 4/10 Entry $3.33 to $3.56 Now $3.60 +8.11% ▲ +6.91% +5.59% vs SPY
- Nov 9, 20267d ago SC 13G/A Neutral 3/10 Entry $3.53 to $3.33 Now $3.60 +1.98% ▼ −5.67% −5.30% vs SPY
- Nov 2, 202614d ago Press Release Neutral 2/10 Entry $3.46 to $3.53 Now $3.60 +4.20% ▲ +2.17% +1.87% vs SPY
- Oct 30, 202617d ago SC 13G/A Neutral 3/10 Entry $3.94 to $3.46 Now $3.60 −8.63% ▼ −12.31% −11.83% vs SPY
- Sep 17, 20268w ago SC 13D Bullish 6/10 Entry $3.56 to $3.69 Now $3.60 +1.12% ▲ +3.65% +2.10% vs SPY
- Jul 23, 202616w ago Court Ruling Neutral 3/10 Viewing Entry $3.97 to $3.96 Now $3.60 −9.32% ▼ −0.25% −0.27% vs SPY
- Jun 12, 202622w ago Institutional Cluster Mixed 4/10 Entry $4.18 to $4.17 Now $3.60 −13.88% ▼ −0.24% −2.00% vs SPY
- Jun 3, 202623w ago 8-K Neutral 3/10 Entry $4.17 to $4.04 Now $3.60 −13.67% ▼ −3.12% −0.52% vs SPY
- May 6, 202627w ago 8-K Bearish 6/10 Entry $3.13 to $3.06 Now $3.60 −15.02% ▲ +2.24% +3.07% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time Court Ruling Intelligence
Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more, parsed and scored by AI.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers